Chemotype Cbd Rich

CBD-rich chemotypes represent cannabis plants selectively bred to express elevated cannabidiol (CBD) levels relative to THC, typically resulting in ratios of 1:1 or higher CBD-to-THC, or CBD-dominant profiles with minimal THC. These chemotypes emerged from breeding programs in the 1990s-2000s, drawing from landrace genetics and modern hybridization techniques. The trait is polygenic and environmentally influenced, making consistent CBD expression require stable genetics and controlled cultivation. Breeders working in this category often select parent plants through cannabinoid testing before crossing, establishing F1 and stabilized F2+ lines. CBD-rich chemotypes have become foundational in the broader cannabis genetics landscape, supporting both research-focused cultivation and regulated markets seeking consistent cannabinoid profiles.

Breeders pursuing CBD-rich lines typically employ marker-assisted selection and multi-generational testing to stabilize high-CBD expression while managing THC ratios. Understanding the genetic basis of this chemotype is critical for crossing programs aiming to introduce CBD traits into existing strain families without losing desired morphology or terpene profiles.